Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1087-1098
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1087
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1087
Abdominal obesity | Hypertension | Dyslipidemia | Fasting glucose | |
IDF central obesity + 2 of 4 criteria in adult patients and children aged >10 yr[87-89] | 10–15 yr old waist circumference (WC) ≥ 90th percentile for age and sex | Systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg | TG ≥ 150 mg/dL or specific treatment HDL < 40 mg/dL (male), HDL < 50 mg/dL (female) | ≥ 100 mg/dL or diagnosis of type 2 diabetes mellitus |
>15 yr old WC ≥ 94 cm (male) b WC ≥ 80 cm (female) | ||||
Panel: IDEFICS definition of metabolic syndrome in children aged 2–11 yr[90]1 | 10–15 yr old WC ≥ 90th percentile for age and sex | Blood pressure: systolic ≥ | TG: ≥ 90th percentile or HDL cholesterol: ≤ 10th percentile | Insulin ≥ 90th percentile or fasting glucose ≥ 90th percentile |
> 15 yr old adults criteria |
- Citation: Lanzaro F, Guarino S, D'Addio E, Salvatori A, D'Anna JA, Marzuillo P, Miraglia del Giudice E, Di Sessa A. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World J Hepatol 2022; 14(6): 1087-1098
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1087.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1087